Silverarc Capital Management, LLC Surface Oncology, Inc. Transaction History

Silverarc Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.73 - $7.9 $236,500 - $395,000	-50,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.16 - $7.98 $229,821 - $355,421	-44,539 Reduced 47.11%	50,000 $379,000
Q2 2021 Aug 16, 2021	SELL	$6.45 - $9.09 $35,223 - $49,640	-5,461 Reduced 5.46%	94,539 $705,000
Q1 2021 May 18, 2021	SELL	$7.25 - $13.82 $217,500 - $414,600	-30,000 Reduced 23.08%	100,000 $780,000
Q4 2020 Feb 16, 2021	BUY	$6.87 - $10.48 $893,100 - $1.36 Million	130,000 New	130,000 $1.2 Million

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.